MiR-1307 Promotes Hepatocarcinogenesis by CALR-OSTC-endoplasmic Reticulum Protein Folding Pathway
Overview
Affiliations
miR-1307 is highly expressed in liver cancer and inhibits methyltransferase protein8. Thereby, miR-1307 inhibits the expression of KDM3A and KDM3B and increases the methylation modification of histone H3 lysine 9, which enhances the expression of endoplasmic-reticulum-related gene CALR. Of note, miR-1307 weakens the binding ability of OSTC to CDK2, CDK4, CyclinD1, and cyclinE and enhances the binding ability of CALR to CDK2, CDK4, CyclinD1, and cyclinE, decreasing of p21WAF1/CIP1, GADD45, pRB, and p18, and decreasing of ppRB. Furthermore, miR-1307 increases the activity of H-Ras, PKM2, and PLK1. Strikingly, miR-1307 reduces the binding ability of OSTC to ATG4 and enhances the binding ability of CALR to ATG4. Therefore, miR-1307 reduces the occurrence of autophagy based on ATG4-LC3-ATG3-ATG7-ATG5-ATG16L1-ATG12-ATG9- Beclin1. In particular, miR-1307 enhances the expression of PAK2, PLK1, PRKAR2A, MYBL1, and Trim44 and inhibits the expression of Sash1 and Smad5 via autophagy. Our observations suggest that miR-1307 promotes hepatocarcinogenesis by CALR-OSTC-endoplasmic reticulum protein folding pathway.
Ghosh S, Thamotharan S, Fong J, Lei M, Janzen C, Devaskar S Sci Rep. 2024; 14(1):16770.
PMID: 39039088 PMC: 11263608. DOI: 10.1038/s41598-024-64057-w.
Epigenetic roles of KDM3B and KDM3C in tumorigenesis and their therapeutic implications.
Yoo J, Kim G, Jeon Y, Lee S, Kwon S Cell Death Dis. 2024; 15(6):451.
PMID: 38926399 PMC: 11208531. DOI: 10.1038/s41419-024-06850-z.
Zhu Q, Wang F, Gao D, Gao J, Li G, Jiao D Cell Prolif. 2023; 56(11):e13487.
PMID: 37190930 PMC: 10623960. DOI: 10.1111/cpr.13487.
Timofeeva A, Fedorov I, Sukhova Y, Ivanets T, Sukhikh G Int J Mol Sci. 2023; 24(9).
PMID: 37175711 PMC: 10178353. DOI: 10.3390/ijms24098006.
Wu J, Zhu Y, Cong Q, Xu Q Oncol Rep. 2023; 49(6).
PMID: 37083063 PMC: 10170481. DOI: 10.3892/or.2023.8550.